Genmab adds more ADC firepower with $1.8B ProfoundBio acquisition

The latest stories trending on MedCity News.

Editor's Pick

Top Story Genmab Adds More ADC Firepower With $1.8B ProfoundBio Acquisition Antibody specialist Genmab makes most of its money from drugs developed and commercialized by partners. Acquiring ProfoundBio brings antibody drug conjugates that Genmab can develop on its own as it continues diversifying its business beyond strategic alliances. Great Networking "Great networking, venue was outstanding, a lot of fun. This was without a doubt the best event of its type I have ever attended." ~ J. June, CEO Ischemia Care Don't miss your opportunity to join us. You can still save $100 with the advanced rate. Register Now

Featured News

Boutique Healthcare Investment Event in Chicago Highlights AI, Government Funding, Value-Based Care. Register Today! The MedCity INVEST conference is scheduled for May 21-22 at the Ritz Carlton hotel in Chicago. In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities. Ardent Health Opts for New Employee Benefits and Employee Experience with Quantum Health and Imagine360 Quantum Health CEO Zane Burke and Imagine360 CEO Jeff Bak highlighted the significance of the partnership, what it means for their respective businesses, and the industry at large, in response to emailed questions. Supplemental Benefits Must Return to Value In a new era of cost-conscientiousness in MA, supplemental benefits will be assessed on their usefulness — to both payers and beneficiaries 200 Stakeholders Push DEA for Updated Proposed Rule on Virtual Prescribing of Controlled Substances In a letter, several stakeholders urged the Drug Enforcement Administration to release a revised proposed rule on the virtual prescribing of controlled substances. This comes as Covid-19 flexibilities that allow controlled substances to be prescribed via telehealth without an in-person exam are set to expire at the end of the year. Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The tool, which was developed in collaboration with Mayo Clinic, is embedded into Eko's digital stethoscopes.

Resources

The Everybody Covered Campaign In this episode of MedCity FemFwd, we're joined by Millicent Gorham, CEO of the Alliance for Women's Health and Prevention (AWHP). AWHP recently launched the EveryBODY Covered campaign, which is advocating for comprehensive coverage of obesity care. Gorham discusses the current state of obesity treatment for women and her goals for the campaign. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe